3'-O-DMT-α-L-threofuranosyl-U-2'-CE-Phosphoramidite
3'-O-DMT-α-L-threofuranosyl-U-2'-CE-Phosphoramidite - N (Normal) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Related Products
Specifications
Specifications
-
Catalog No.PR5-108
-
SMILESCC(C)N(C(C)C)P(OCCC#N)O[C@H]1[C@@H](OCC(N(C)C)=O)[C@H](N2C(NC(C(C)=C2)=O)=O)O[C@@H]1COC(C3=CC=CC=C3)(C4=CC=C(OC)C=C4)C5=CC=C(OC)C=C5
-
Molecular FormulaC38H45N4O8P
-
Molecular Weight716.77
-
AppearanceReport result
-
PurityHPLC≥95%
-
Storage Condition-20℃
Documentation
Documentation
-
Catalog No.PR5-108
-
SMILESCC(C)N(C(C)C)P(OCCC#N)O[C@H]1[C@@H](OCC(N(C)C)=O)[C@H](N2C(NC(C(C)=C2)=O)=O)O[C@@H]1COC(C3=CC=CC=C3)(C4=CC=C(OC)C=C4)C5=CC=C(OC)C=C5
-
Molecular FormulaC38H45N4O8P
-
Molecular Weight716.77
-
AppearanceReport result
-
PurityHPLC≥95%
-
Storage Condition-20℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
